Pharmafile Logo

Electronic medical records and doctor/patient communication

April 2, 2015 |  

View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.

What seems to get US doctors I talk to most agitated is an aspect of Obamacare that gets relatively little attention outside the healthcare community:  the “forced” conversion of medical practices to electronic medical records (EMR).
Under legislation signed in 2009, physicians were given a January 2015 deadline to convert to EMR and show “meaningful use” of these systems or face lower reimbursement rates on Medicare physician fees – a penalty of 1 percent of Medicare payments, increasing to 2 percent in 2016 and 3 percent in 2017.  To help offset the cost of EMR conversion, the federal government is offering individual practitioners up to $44,000 in incentive payments under the American Recovery and Reinvestment Act.  With both a carrot and a stick in place, physician practices, large and small, have been converting en masse.  

For many US physician practices, implementing EMR software and converting paper patient records to electronic form has been massively disruptive, as well as costly.  My own primary care practice, a small physician group, cut back on the number of patients seen per day for several months while their doctors and staff learned the new system.
Even with the financial and administrative challenges, what some doctors find to be the most difficult aspect of the conversion to EMR is the way it impacts the daily practice of medicine by changing how they communicate with patients, and thus altering the doctor-patient relationship.  With increasing time pressures, some clinicians feel they need to type into their computer or tablet while talking to patients, their face buried in the screen.  Many  find this takes their focus away from what the patient is saying, and leads them to miss picking up on some cues, or gaining a more holistic understanding of the patient.  On the other hand, some believe the greater access to information through the EMR system, and elimination of the need to scan through paper records, improves patient care.

A 2008 study conducted by the Center for Studying Health System Change found EMR systems both help and hinder communication between doctors and patients, as well as clinician-clinician interactions.  As system designs improve and physicians gain increasing familiarity with the technology, the positives should outpace the negatives.  Certainly, for the new generation of physicians (like my daughter, who is a third year medical student), who are learning the practice of medicine with these tools, the use of EMR should be second nature.

As a market researcher, who has seen MR evolve from largely face-to-face to largely web-based, I wonder if there are parallels for our industry…  Is our evolving technology promoting or hindering engaging in dialogue with respondents?  It certainly is possible for researchers to be distracted by the “latest and greatest” technological innovation in MR.  The key is to be able to leverage our technology to gain richer insights and understanding, not simply more data.

Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1FbCHZG

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Emerging Markets: Your Essential Guide

Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges...

Live webinar: Navigating new frontiers: Ways to find space in the future RA market

In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...

New appointments in our UK and New York offices

Research Partnership is delighted to announce various appointments across our offices. Ella Buckland joins as Research Executive, Ines Belchior joins as Research Analyst, and Emma Warburton joins as Business Development...

Pharma Market Research Conference NJ, 2019

We are delighted to be presenting and exhibiting at PMRC, 6-7 February in Newark, NJ.Representing Research Partnership at the conference will be New York-based Directors Liza Pliss and Mariana Servin.Liza...

Research Partnership ranks 13th in the top 20 fastest-growing agencies in the UK

The UK’s best performing market research agencies were revealed earlier this month with the publication of Research Live’s Industry Report for 2019, which includes the latest Market Research Society (MRS)...

Vaccines: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the area of vaccines. The infographic also includes links to a range of...

Conference Live: Case study

How we helped track and evaluate conference performance over time across multiple international events

Live Webinar: Poker face revealed: Using facial analysis to reveal deeper emotional insights

Thursday 28th February 2019, 10:00 EST / 15:00 GMT / 16:00 CET

Live from Singapore: Oncology in APAC – Evaluating the opportunity for novel therapies

Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST

Live webinar: Optimise your digital assets with UX research

Thursday 25th October 2018 11:00 EDT / 16:00 BST / 17:00 CEST